Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?

Eur J Endocrinol. 2010 Jan;162(1):91-9. doi: 10.1530/EJE-09-0775. Epub 2009 Oct 1.

Abstract

Objective: Few data are available regarding the need of steroid substitutive therapy after unilateral adrenalectomy for adrenal incidentaloma (AI). It is unknown whether, before surgery, the hypothalamic-pituitary-adrenal (HPA) axis secretion parameters can predict post-surgical hypocortisolism.

Aim: This study aimed to evaluate whether, in AI patients undergoing unilateral adrenalectomy, post-surgical hypocortisolism could be predicted by the parameters of HPA axis function.

Design: Prospective, multicenter.

Methods: A total of 60 patients underwent surgical removal of AI (surgical indication: 29 subclinical hypercortisolism (SH); 31 AI dimension). Before surgery, SH was diagnosed in patients presenting at least three criteria out of urinary free cortisol (UFC) levels>60 microg/24 h, cortisol after 1-mg dexamethasone suppression test (1 mg-DST)>3.0 microg/dl, ACTH levels<10 pg/ml, midnight serum cortisol (MSC)>5.4 microg/dl. Two months after surgery, HPA axis function was assessed by low dose ACTH stimulation test or insulin tolerance test when needed: 39 patients were affected (Group B) and 21 were not affected (Group A) with hypocortisolism. The accuracy in predicting hypocortisolism of pre-surgical HPA axis parameters or their combinations was evaluated.

Results: The presence of >2 alterations among 1 mg-DST>5.0 microg/dl, ACTH<10 pg/ml, elevated UFC and MSC has the highest odds ratio (OR) for predicting post-surgical hypocortisolism (OR 10.45, 95% confidence interval, CI 2.54-42.95, P=0.001). Post-surgical hypocortisolism was predicted with 100% probability by elevated UFC plus MSC levels, but not ruled out even in the presence of the normality of all HPA axis parameters.

Conclusion: Post-surgical hypocortisolism cannot be pre-surgically ruled out. A steroid substitutive therapy is indicated after unilateral adrenalectomy for SH or size of the adenoma.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Neoplasms / blood*
  • Adrenal Cortex Neoplasms / surgery
  • Adrenalectomy / adverse effects
  • Adrenocortical Adenoma / blood*
  • Adrenocortical Adenoma / surgery
  • Adult
  • Aged
  • Cushing Syndrome / blood*
  • Cushing Syndrome / diagnosis
  • Cushing Syndrome / etiology
  • Endocrine Surgical Procedures / adverse effects*
  • Female
  • Follow-Up Studies
  • Humans
  • Hydrocortisone / blood
  • Incidental Findings*
  • Male
  • Middle Aged
  • Postoperative Complications / blood*
  • Postoperative Complications / diagnosis
  • Postoperative Complications / etiology
  • Predictive Value of Tests
  • Preoperative Care / standards*
  • Prospective Studies
  • Sensitivity and Specificity
  • Young Adult

Substances

  • Hydrocortisone